Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 24, 2021

SELL
$7.99 - $15.0 $12,144 - $22,800
-1,520 Closed
0 $0
Q4 2020

May 24, 2021

BUY
$7.04 - $11.7 $10,700 - $17,784
1,520 New
1,520 $12,000
Q4 2020

May 24, 2021

SELL
$7.04 - $11.7 $10,700 - $17,784
-1,520 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$16.62 - $23.92 $25,262 - $36,358
1,520 New
1,520 $28,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.